Cencora, Inc.

CORSEC EDGAR

Wholesale-Drugs, Proprietaries & Druggists' Sundries(DE)CIK: 1140859

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Revenues	$262.2B	$238.6B	$214.0B	$189.9B	$179.6B
Cost of Goods and Services Sold	$253.2B	$230.3B	$207.0B	$184.7B	$174.5B
Gross Profit	$9.0B	$8.3B	$6.9B	$5.2B	$5.1B
Selling, General and Administrative Expense	$5.3B	$4.8B	$3.6B	$2.8B	$2.7B
Operating Expenses	$5.7B	—	—	—	—
Operating Income (Loss)	$2.3B	$2.4B	$2.4B	-$5.1B	$1.1B
Nonoperating Income (Expense)	$49.0M	$27.4M	$41.7M	$1.6M	$13.0M

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Assets	$67.1B	$62.6B	$56.6B	$57.3B	$44.3B
Assets, Current	$47.7B	$42.8B	$39.6B	$38.8B	$33.1B
Cash and Cash Equivalents, at Carrying Value	$3.4B	$2.5B	$2.5B	$4.6B	$4.6B
Accounts Receivable, after Allowance for Credit Loss, Current	$23.9B	$20.9B	$18.5B	$18.2B	$13.8B
Inventory, Net	$19.0B	$17.5B	$15.6B	$15.4B	$12.6B
Liabilities, Current	$54.3B	$48.8B	$43.5B	$41.4B	$33.9B
Long-term Debt	$4.4B	$4.8B	$5.7B	$6.7B

Concept	FY2025	FY2024	FY2023	FY2022	FY2021
Net Cash Provided by (Used in) Operating Activities	$3.9B	$2.7B	$2.7B	$2.2B	$2.3B
Net Cash Provided by (Used in) Investing Activities	-$2.6B	-$368.4M	-$6.1B	-$379.9M	-$375.8M
Net Cash Provided by (Used in) Financing Activities	-$2.2B	-$1.8B	$2.0B	-$603.6M	-$1.1B
Payments to Acquire Property, Plant, and Equipment	$458.4M	$496.3M	$438.2M	$369.7M	$310.2M
Payments of Ordinary Dividends, Common Stock	$398.8M	$391.7M	$366.6M	$343.6M	$339.0M
Payments for Repurchase of Common Stock	$1.2B	$483.7M	$82.2M	$420.4M	$674.0M

Access SEC EDGAR data via REST API. Free tier available.

from sec_edgar import SecEdgar

api = SecEdgar("YOUR_KEY")
api.revenue("AAPL", limit=5)